SAM #HT940827Q0001

DHA sole-source notice for an OssaTron shock wave therapy device

The Defense Health Agency is pursuing a five-year, sole-source requirement for an OssaTron shock wave therapy device for Wilford Hall Medical Center. - Government buyer: Defense Health Agency (DHA), Healthcare Contracting Division – San Antonio, supporting Wilford Hall Medical Center. - Named vendor: Premier Shockwave is the intended sole-source awardee. The notice does not identify the device’s manufacturer separately. - Product: One OssaTron extracorporeal shock wave therapy (ESWT) device; no quantity or part number is specified. - Delivers high-energy shock wave therapy for chronic orthopedic conditions, including chronic plantar fasciitis and chronic lateral epicondylitis. - Period: Five years; start and end dates are not specified. - Notable requirement: The notice describes an intended sole-source award and is not a request for offers.

Description

Notice of intent

Healthcare Contracting Division – San Antonio, in support of Wilford Hall Medical Center intends to award a sole source contract to Premier Shockwave. for The OssaTron a medical device that delivers high-energy extracorporeal shock wave therapy (ESWT)—acoustic shock waves applied from outside the body.

OssaTron is used for certain chronic orthopedic conditions that did not improve with conservative treatment, including: Chronic plantar fasciitis (persistent heel pain)

Chronic lateral epicondylitis (“tennis elbow”).  The service being requested is for a five-year period. The NAICS code 334510 Electromedical and Electrotherapeutic Apparatus, Manufacturing size standard is 1,250 employees. This notice is neither a request for quotes nor a solicitation of offers; however, all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency for future requirements.

View original listing